Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 11, 2025International Urology and NephrologyOpen Access

High-density lectin microarray uncovers stage-specific plasma glycoprofiling signatures for non-muscle-invasive and muscle-invasive bladder cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

XXXiansheng XiangMXMei XueXSXiaojing Song

Discussion

Loading...

Member takes

Overview

Pilot study uncovers glycan signatures in non-muscle-invasive and muscle-invasive bladder cancer, suggesting new biomarkers.

Key Points

  • Stage-specific glycoprofiling reveals unique plasma signatures for bladder cancer types, facilitating diagnostic accuracy.
  • Unique glycosylation patterns in NMIBC and MIBC were identified, with distinct associated metrics indicating their significance.
  • Leveraging a high-density microarray approach, a comprehensive analysis was conducted across 48 plasma samples from differing patient groups.
  • Findings highlight the potential of glycoprofiling as a tool for bladder cancer diagnostics, needing further validation in larger cohorts.

Cite This Study

Xiang et al. (2025) studied this question.

synapsesocial.com/papers/68a360e70a429f7973329757https://doi.org/10.1007/s11255-025-04708-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Stage-Specific Molecular Signatures and Prognostic Biomarkers2025
  2. 2Plasma metabolomic profiling identifies a metabolic signature for non–muscle-invasive bladder cancer independent of hematuria2026
  3. 3Serum Galectin-3 as a complementary biomarker in non-muscle-invasive bladder cancer2026
  4. 4B-017 Benchtop glyco-analyzer: from development of biomarker to potential use in clinical setting2024
  5. 5Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer2024 · 1 citations